Table 3.

Changes in bone markers according to the duration of the disease and steroid combination.

	Osteocalcin	P*	Bone ALP	P**
Disease duration		0.009		0.050
<6 months
Pretreatment	18.6 ± 13.9		29.3 ± 18.8
Posttreatment	19.6 ± 24.3		25.7 ± 13.0
Difference	1.2 ± 24.1		4.2 ± 17.0
P*	0.058		0.088
≥6 months
Pretreatment	13.9 ± 19.6		23.4 ± 14.0
Posttreatment	10.1 ± 9.7		18.0 ± 6.4
Difference†	4.9 ± 13.3		5.5 ± 12.4
P*	<0.0001		0.002
Steroid
Combination
Pretreatment	16.5 ± 18.0		27.3 ± 18.0
Posttreatment	13.6 ± 15.6		22.0 ± 10.5
Difference	4.2 ± 18.7		5.4 ± 15.7
P*	0.0002		0.001
Without combination
Pretreatment	15.5 ± 12.1		22.7 ± 9.3
Posttreatment	20.5 ± 30.9		20.9 ± 13.2
Difference	−2.8 ± 22.3		2.1 ± 9.0
P*	0.153		0.275

*P value represents difference from pretreatment value to posttreatment value within each group.

**P value represents difference of treatment outcome by prevalence duration.

^†Posttreatment value − pretreatment value.